(Q41658732)

6 October 2017

title

Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies (English)

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

8 November 2022

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

8 November 2022

author name string

Morel-Fourrier B

4

1 reference

6 October 2017

J. Wijdenes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

C. Clement

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

B. Klein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

B. Morel-Fourrier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

N. Vita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

P. Ferrara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

A. Peters

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1720501

8 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1720501

8 November 2022

publication date

1 November 1991

1 reference

full work available at URL

6 October 2017

https://api.elsevier.com/content/article/PII:0161589091900044?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

https://api.elsevier.com/content/article/PII:0161589091900044?httpAccept=text/plain

8 November 2022

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

8 November 2022

1 reference

6 October 2017

volume

28

1 reference

6 October 2017

issue

11

1 reference

6 October 2017

page(s)

1183-1192

1 reference

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

6 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

8 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

8 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Epitope mapping of recombinant human gamma interferon using monoclonal antibodies

8 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man

8 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients

8 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro

8 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin-6 and the acute phase response

8 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin 6 is involved in interleukin 1-induced activities

8 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

8 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

8 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Involvement of IL-6 in mesangial proliferative glomerulonephritis

8 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Synergistic activation of human T cells by interleukin 1 and interleukin 6

8 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides

8 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis

8 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Constitutive production of interleukin-6 and immunologic features in cardiac myxomas

8 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

8 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma

8 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha

8 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

8 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.

8 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

8 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

16 Methods for assessing immunologic and biologic properties of iodinated peptide hormones

8 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

8 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases

8 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes

8 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)

8 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

8 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

Interleukin-6 in synovial fluid from patients with arthritis

8 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0161-5890(91)90004-4

8 November 2022

Identifiers

1 reference

6 October 2017

1 reference